Jean-Jacques Grob

Author PubWeight™ 95.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med 2011 26.90
2 Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial. Lancet 2012 13.89
3 Randomized controlled trial testing the impact of high-protection sunscreens on sun-exposure behavior. Arch Dermatol 2005 9.42
4 Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study. Lancet Oncol 2009 8.68
5 A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 2011 3.53
6 Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline. Eur J Cancer 2009 2.26
7 Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma. J Clin Oncol 2013 2.13
8 Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline--Update 2012. Eur J Cancer 2012 2.05
9 The role of BRAF V600 mutation in melanoma. J Transl Med 2012 2.00
10 Randomized clinical trials for psoriasis 1977-2000: the EDEN survey. J Invest Dermatol 2003 1.77
11 Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma. J Clin Oncol 2013 1.67
12 The "spaghetti technique": an alternative to Mohs surgery or staged surgery for problematic lentiginous melanoma (lentigo maligna and acral lentiginous melanoma). J Am Acad Dermatol 2011 1.50
13 Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 2004 1.46
14 Pepper mild mottle virus, a plant virus associated with specific immune responses, Fever, abdominal pains, and pruritus in humans. PLoS One 2010 1.21
15 French people and skin diseases: results of a survey using a representative sample. Arch Dermatol 2003 1.11
16 An exploratory study of systemic administration of the toll-like receptor-7 agonist 852A in patients with refractory metastatic melanoma. Clin Cancer Res 2008 1.10
17 Superiority of a cognitive education with photographs over ABCD criteria in the education of the general population to the early detection of melanoma: a randomized study. Int J Cancer 2006 1.08
18 A severe case of ipilimumab-induced guillain-barré syndrome revealed by an occlusive enteric neuropathy: a differential diagnosis for ipilimumab-induced colitis. J Immunother 2013 1.06
19 Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy. Int J Radiat Oncol Biol Phys 2006 1.02
20 Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients. J Immunother 2008 0.96
21 Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study. J Invest Dermatol 2014 0.94
22 The CareGiver Oncology Quality of Life questionnaire (CarGOQoL): development and validation of an instrument to measure the quality of life of the caregivers of patients with cancer. Eur J Cancer 2011 0.92
23 Ipilimumab in melanoma patients with brain metastasis: a retro-spective multicentre evaluation of thirty-eight patients. Acta Derm Venereol 2014 0.91
24 Risk factors in elderly people for lentigo maligna compared with other melanomas: a double case-control study. Arch Dermatol 2009 0.91
25 Ara h 2 and Ara h 6 sensitization predicts peanut allergy in Mediterranean pediatric patients. Pediatr Allergy Immunol 2014 0.84
26 Slow dynamics of lymphoscintigraphic mapping is associated to the negativity of the sentinel node in melanoma patients. Ann Surg Oncol 2008 0.81
27 Quality of life in alopecia areata: a study of 60 cases. J Invest Dermatol 2010 0.80
28 Induction of IP-10/CXCL10 secretion as an immunomodulatory effect of low-dose adjuvant interferon-alpha during treatment of melanoma. Immunobiology 2009 0.80
29 Treatment algorithms in stage IV melanoma. Am J Ther 2015 0.80
30 Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial. Am J Clin Dermatol 2007 0.80
31 Killing efficacy of a new silicon phthalocyanine in human melanoma cells treated with photodynamic therapy by early activation of mitochondrion-mediated apoptosis. Exp Dermatol 2004 0.80
32 Randomized controlled study of electrochemotherapy in the local treatment of skin metastases of melanoma. J Cutan Med Surg 2007 0.78
33 Sinonasal mucosal melanomas: the prognostic value of tumor classifications. Head Neck 2013 0.78
34 Management of adult patients with cutaneous melanoma without distant metastasis. 2005 update of the French Standards, Options and Recommendations guidelines. Summary report. Eur J Dermatol 2007 0.77
35 Analysis of T-cell receptor-γ gene rearrangements using heteroduplex analysis by high-resolution microcapillary electrophoresis. Leuk Res 2012 0.77
36 Meeting report from the Third Global Workshop on Melanoma. Pigment Cell Melanoma Res 2010 0.76
37 [Clinical practice guideline: 2005 update of recommendations for the management of patients with cutaneous melanoma without distant metastases (summary report)]. Bull Cancer 2006 0.76
38 A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma. Cancer 2014 0.75
39 Evidence of a limited intra-individual diversity of nevi: intuitive perception of dominant clusters is a crucial step in the analysis of nevi by dermatologists. J Invest Dermatol 2013 0.75
40 Localized skin necrosis of steroid-induced striae distensae: an unusual complication of bevacizumab and irinotecan therapy. Arch Dermatol 2011 0.75
41 LMNA, ZMPSTE24, and LBR are not mutated in scleroderma. Genet Test Mol Biomarkers 2009 0.75
42 [Therapy algorithm for cutaneous T-cell lymphomas]. Ann Dermatol Venereol 2005 0.75
43 [Kinetic values of lymphoscintigraphy of sentinel ganglion in cutaneous cervicofacial melanomas]. J Otolaryngol Head Neck Surg 2010 0.75
44 Congenital and disseminated pyogenic granuloma-like vascular lesions. Acta Derm Venereol 2015 0.75